Recursion Pharmaceuticals, Inc. (RXRX) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Snapshot as of Apr 24, 2026.

Spot Price

$3.51

Max Pain Strike

$4.50

Total OI

354.8K

As of Apr 24, 2026, Recursion Pharmaceuticals, Inc. (RXRX) max pain sits at $4.50, which is above the current spot price of $3.51 (28.2% away). Max pain identifies the strike at which the aggregate dollar value of all outstanding options contracts would expire with the least total intrinsic value — a gravitational center, not a price target. The pinning effect typically strengthens into expiration as gamma concentrates at high-open-interest strikes.